MMCAP International Inc. SPC purchased a new stake in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 350,000 shares of the company’s stock, valued at approximately $6,454,000. Translational Development Acquisition comprises about 1.0% of MMCAP International Inc. SPC’s investment portfolio, making the stock its 27th biggest holding.
Several other hedge funds have also modified their holdings of the stock. Tuttle Capital Management LLC acquired a new position in Translational Development Acquisition in the fourth quarter valued at approximately $461,000. Wolverine Asset Management LLC acquired a new position in Translational Development Acquisition in the fourth quarter valued at approximately $5,716,000. Finally, Calamos Advisors LLC acquired a new position in Translational Development Acquisition in the fourth quarter valued at approximately $6,915,000.
Translational Development Acquisition Trading Up 0.1 %
Shares of NASDAQ TDACU opened at $10.13 on Wednesday. The firm has a 50 day simple moving average of $10.05. Translational Development Acquisition Corp. has a fifty-two week low of $10.00 and a fifty-two week high of $10.30.
Translational Development Acquisition Company Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Further Reading
- Five stocks we like better than Translational Development Acquisition
- Which Wall Street Analysts are the Most Accurate?
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The How And Why of Investing in Oil Stocks
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Why Are Stock Sectors Important to Successful Investing?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
